165 related articles for article (PubMed ID: 6437941)
1. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
Perret BA; Furlan M; Beck EA
Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
[TBL] [Abstract][Full Text] [Related]
2. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
Mazurier C; Samor B; Deromeuf C; Goudemand M
Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
[TBL] [Abstract][Full Text] [Related]
3. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
Zhou FL; Burnouf-Radosevich M; Burnouf T
Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
[TBL] [Abstract][Full Text] [Related]
4. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
Johnson AJ; Macdonald VE; Brind J
Vox Sang; 1979; 36(2):72-6. PubMed ID: 313629
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the von Willebrand factor/factor VIII complex produced by a novel purification process.
Ahn JW; Chang ES; Jung YJ; Kim SR; Seong BL; Ha SH
Arch Pharm Res; 2020 Jul; 43(7):714-723. PubMed ID: 32666302
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
Burnouf-Radosevich M; Burnouf T
Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
[TBL] [Abstract][Full Text] [Related]
7. Dispersity of human factor VIII--Von Willebrand factor.
van Mourik JA; Bolhuis PA
Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
[No Abstract] [Full Text] [Related]
8. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
Switzer ME; McKee PA
J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
[TBL] [Abstract][Full Text] [Related]
9. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
Meyer D; Obert B; Pietu G; Lavergne JM; Zimmerman TS
J Lab Clin Med; 1980 Apr; 95(4):590-602. PubMed ID: 6965697
[TBL] [Abstract][Full Text] [Related]
10. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
Counts RB; Paskell SL; Elgee SK
J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
[TBL] [Abstract][Full Text] [Related]
11. The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matrices.
Saundry RH; Savidge GF
Bioseparation; 1991; 2(3):177-86. PubMed ID: 1368084
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
[TBL] [Abstract][Full Text] [Related]
13. Investigation of a coagulation accelerating factor (CAF) in glomerulonephritis.
Salem HH; Howard MA; Koutts J; Firkin BG
Br J Haematol; 1985 Mar; 59(3):485-96. PubMed ID: 3918561
[TBL] [Abstract][Full Text] [Related]
14. Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration.
Kaersgaard P; Barington KA
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):357-67. PubMed ID: 9792522
[TBL] [Abstract][Full Text] [Related]
15. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf).
Samor B; Mazurier C; Goudemand M; Debeire P; Fournet B; Montreuil J
Thromb Res; 1982 Jan 1-15; 25(1-2):81-9. PubMed ID: 6801813
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
18. Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue.
McComb RD; Jones TR; Pizzo SV; Bigner DD
J Histochem Cytochem; 1982 Apr; 30(4):371-7. PubMed ID: 6801111
[TBL] [Abstract][Full Text] [Related]
19. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
20. Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow.
Parker ET; Lollar P
J Biol Chem; 2021; 296():100420. PubMed ID: 33600794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
